naproxen


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to naproxen: cyclobenzaprine

na·prox·en

 (nə-prŏk′sən)
n.
A nonsteroidal anti-inflammatory drug, C14H14O3, used to treat fever and pain.

[Shortening and alteration of methoxynaphthylpropionic acid, one of its chemical names.]

naproxen

(nəˈprɒksɛn)
n
(Pharmacology) a drug with anti-inflammatory and pain-relieving properties

na•prox•en

(nəˈprɒk sən)

n.
a nonsteroidal anti-inflammatory substance, C14H14O3.
[by shortening and rearrangement of methoxy-, naphthyl-, and propionic, components of one of its chemical names]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.naproxen - a nonsteroidal anti-inflammatory drug (trade name Naprosyn) used in the treatment of arthritis and musculoskeletal inflammation and moderate pain
nonsteroidal anti-inflammatory, nonsteroidal anti-inflammatory drug, NSAID - an anti-inflammatory drug that does not contain steroids; "NSAIDs inhibit the activity of both Cox-1 and Cox-2 enzymes"
propanoic acid, propionic acid - a liquid fatty acid found in milk and sweat and in fuel distillates
Translations

naproxen

n naproxeno
References in periodicals archive ?
The study was conducted in 240 healthy volunteers and is designed to demonstrate the superiority of ATB-346 in gastrointestinal safety compared to naproxen.
PRECISION-ABPM, a four-month sub-study of the Cleveland Clinic-led PRECISION trial, evaluated the blood pressure effects of prescription ibuprofen (Advil[R], Motrin[R]), naproxen (Aleve[R]) and celecoxib (Celebrex[R]) among 444 patients, average age 62, with arthritis who had heart disease or were at increased risk for it.
BARCELONA -- Prescription-strength ibuprofen has a bigger adverse effect on blood pressure than celecoxib or naproxen, a finding that suggests a likely mechanism for the worse cardiovascular event rate documented in ibuprofen-treated arthritis patients in the PRECISION trial, Frank Ruschitzka, MD, said at the annual congress of the European Society of Cardiology.
BARCELONA--Prescription-strength ibuprofen has a bigger adverse effect on blood pressure than celecoxib or naproxen, a finding that suggests a likely mechanism for the worse cardiovascular event rate documented in ibuprofen-treated arthritis patients in the PRECISION trial, Frank Ruschitzka, MD, said at the annual congress of the European Society of Cardiology.
PRECISION-ABPM, (3) a pre-specified four month substudy of the landmark PRECISION trial, (4) was designed to determine the blood pressure effects of the selective COX-2 inhibitor celecoxib compared to the non-selective NSAIDs naproxen and ibuprofen.
Experts say there is an added danger even within the first week of taking nonsteroidal anti-inflammatory drugs, such as ibuprofen and naproxen.
They found that taking any dose of NSAIDs, including ibuprofen and naproxen, for a week, a month or more than a month was associated with a greater heart attack risk.
5 percent in the naproxen (Aleve, Anaprox) group and 2.
1) Traditional NSAIDs (tNSAIDs), such as aspirin, ibuprofen, naproxen, and diclofenac, represent an effective, long-lasting option that may offer advantages over cyclooxygenase-2 (COX-2) selective NSAIDs, such as celecoxib.
According to the company, VIMOVO (naproxen/esomeprazole magnesium) is a fixed-dose combination of delayed-release enteric-coated naproxen, a non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole magnesium, a stomach acid-reducing proton pump inhibitor (PPI), approved for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.
Researchers from Cleveland Clinic and Brigham and Women's Hospital, Boston, embarked on a 10-year trial (Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen, or PRECISION), involving 24,081 patients in 13 countries to investigate the relative cardiovascular safety of celecoxib compared to ibuprofen and naproxen.
as Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to determine if Celebrex was as safe as two older NSAIDs, naproxen and ibuprofen.